Predicting Melanoma Staging using Targeted RNA Sequencing data using Machine Learning.
Ahmed, F. S.; Irfan, F. B.
Show abstract
The aim of this study is to use machine learning to predict tumor staging and metastasis in melanoma with differentially expressed genes. Machine has been used in different clinical setting to predict different outcomes. However, it has not been used to look at predicting the diagnostic aspect of tumor staging. We used the TCGA RNA-Sequencing data on melanomas to predict tumor staging nodal and/or metastasis using deep neural networks (DNN) and random forest classifier (RF). Results: We were able to predict tumor staging (lower vs higher stage, i.e. Tis / T1 / T2 vs T3 and higher), nodal metastasis and combined nodal or distant metastasis in patients with melanomas with high accuracies. However, we need to further validate these results.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Systems biomedicine of primary and metastatic colorectal cancer reveals potential therapeutic targets 93%
- Patient stratification of clear cell renal cell carcinoma using the global transcription factor activity landscape derived from RNA-seq data 93%
- CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade 92%
Similar papers in this journal
Similar papers in this journal
- Machine learning based prediction of recurrence after curative resection for rectal cancer 95%
- Classification of early and late stage Liver Hepatocellular Carcinoma patients from their genomics and epigenomics profiles. 94%
- Weakly supervised learning for multi-organ adenocarcinoma classification in whole slide images 93%
Similar papers in this journal
- Loss of CHGA protein as a potential biomarker for colon cancer diagnosis: a study on biomarker discovery by machine learning and confirmation by immunohistochemistry in colorectal cancer tissue microarrays 94%
- A novel molecular analysis approach in colorectal cancer suggests new treatment opportunities 92%
- Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.